Our study aimed to assess and compare the diagnostic performance of five biomarkers (AFP, AFP-L3, DCP, CK19, and GPC3) for predicting the likelihood of HCC in a cohort of patients from Western Romania. This evidence concerns the gene GPC3 and hepatocellular carcinoma.